{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:10:01Z","timestamp":1788480601558,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017647","name":"ResMed","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejim.2025.05.028","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T16:06:51Z","timestamp":1749744411000},"page":"106363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6867-5675","authenticated-orcid":false,"given":"TE","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GM","family":"Traaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Aaker\u00f8y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7691-5360","authenticated-orcid":false,"given":"B","family":"\u00d8verland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bendz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AE","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Steinshamn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4900-0453","authenticated-orcid":false,"given":"KH","family":"Haugaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4523-8736","authenticated-orcid":false,"given":"OG","family":"Anfinsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Aukrust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Broch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Akre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JP","family":"Loennechen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gullestad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-0784","authenticated-orcid":false,"given":"T","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.05.028_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010440","article-title":"Obstructive sleep apnea in cardiovascular disease: a review of the literature and proposed multidisciplinary clinical management strategy","volume":"8","author":"Tietjens","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2025.05.028_bib0002","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1093\/eurheartj\/ehad575","article-title":"Adverse outcomes in patients with atrial fibrillation: how previous successes can unmask new challenges","volume":"44","author":"Meyre","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.05.028_bib0003","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.CIR.0000136587.68725.8E","article-title":"Association of atrial fibrillation and obstructive sleep apnea","volume":"110","author":"Gami","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.05.028_bib0004","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1164\/rccm.200509-1442OC","article-title":"Sleep Heart Health S. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study","volume":"173","author":"Mehra","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2025.05.028_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051242","article-title":"Obstructive sleep apnea and atrial fibrillation","volume":"11","author":"Moula","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejim.2025.05.028_bib0006","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.chest.2016.09.014","article-title":"Cardiac arrhythmogenesis: mechanistic insights","volume":"151","author":"May","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2025.05.028_bib0007","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacc.2006.08.060","article-title":"Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.05.028_bib0008","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-3-031-06413-5_4","article-title":"Diagnosis of obstructive sleep apnea in patients with associated comorbidity","volume":"1384","author":"Del Campo","year":"2022","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ejim.2025.05.028_bib0009","article-title":"Atrial fibrillation: comorbidities, lifestyle, and patient factors","volume":"37","author":"Shantsila","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ejim.2025.05.028_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ccep.2020.11.002","article-title":"Implications of inflammation and fibrosis in atrial fibrillation pathophysiology","volume":"13","author":"Harada","year":"2021","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.ejim.2025.05.028_bib0011","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.5664\/jcsm.3070","article-title":"Serum inflammatory markers in obstructive sleep apnea: a meta-analysis","volume":"9","author":"Nadeem","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.ejim.2025.05.028_bib0012","article-title":"Evaluation of blood levels of C-reactive protein marker in obstructive sleep apnea: a systematic review, meta-analysis and meta-regression","volume":"11","author":"Imani","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.ejim.2025.05.028_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107122","article-title":"Adipocytokines in obstructive sleep apnea: a systematic review and meta-analysis","volume":"208","author":"Janmohammadi","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.ejim.2025.05.028_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23104","article-title":"Galectin-3 and risk of atrial fibrillation: a systematic review and meta-analysis","volume":"34","author":"Gong","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.ejim.2025.05.028_bib0015","doi-asserted-by":"crossref","first-page":"E452","DOI":"10.1532\/hsf.2355","article-title":"Predicting value of growth differentiation factor 15 and its correlations with atrial fibrillation","volume":"23","author":"Zhou","year":"2020","journal-title":"Heart Surg Forum"},{"key":"10.1016\/j.ejim.2025.05.028_bib0016","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.repc.2020.07.009","article-title":"Increased serum interleukin-6 level as a predictive biomarker for atrial fibrillation: a systematic review and meta-analysis","volume":"39","author":"Zhou","year":"2020","journal-title":"Rev Port Cardiol (Engl Ed)"},{"key":"10.1016\/j.ejim.2025.05.028_bib0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.amjms.2023.11.009","article-title":"Association of C-reactive protein level with adverse outcomes in patients with atrial fibrillation: a meta-analysis","volume":"367","author":"Zhang","year":"2024","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ejim.2025.05.028_bib0018","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.2147\/JIR.S429892","article-title":"Inflammation and coagulation are two interconnected pathophysiological pathways in atrial fibrillation pathogenesis","volume":"16","author":"Hazarapetyan","year":"2023","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.ejim.2025.05.028_bib0019","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201965RR","article-title":"Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea","volume":"37","author":"Lopez-Galvez","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.ejim.2025.05.028_bib0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.jvca.2015.01.023","article-title":"Low circulating levels of growth differentiation factor-15 before coronary artery bypass surgery may predict postoperative atrial fibrillation","volume":"29","author":"Bouchot","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.ejim.2025.05.028_bib0021","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/14017431.2019.1567933","article-title":"Treatment of sleep apnea in patients with paroxysmal atrial fibrillation: design and rationale of a randomized controlled trial","volume":"52","author":"Traaen","year":"2018","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.ejim.2025.05.028_bib0022","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202011-4133OC","article-title":"Effect of continuous positive airway pressure on arrhythmia in atrial fibrillation and sleep apnea: a randomized controlled trial","author":"Traaen","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2025.05.028_bib0023","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.hrthm.2022.06.016","article-title":"Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: a randomized controlled trial","volume":"19","author":"Hunt","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejim.2025.05.028_bib0024","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2024-002718","article-title":"Cardiac remodelling in patients with atrial fibrillation and obstructive sleep apnoea","volume":"11","author":"Hunt","year":"2024","journal-title":"Open Heart"},{"key":"10.1016\/j.ejim.2025.05.028_bib0025","year":"2014","journal-title":"Am Acad Sleep Med"},{"key":"10.1016\/j.ejim.2025.05.028_bib0026","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.05.028_bib0027","first-page":"258","article-title":"CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"10","author":"Chen","year":"2013","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.ejim.2025.05.028_bib0028","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s11325-020-02144-8","article-title":"Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure","volume":"25","author":"Spiesshoefer","year":"2021","journal-title":"Sleep Breath"},{"key":"10.1016\/j.ejim.2025.05.028_bib0029","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.yjmcc.2009.09.001","article-title":"Extracellular matrix remodeling in atrial fibrosis: mechanisms and implications in atrial fibrillation","volume":"48","author":"Pellman","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.ejim.2025.05.028_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059052","article-title":"Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study","volume":"8","author":"Huxley","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2025.05.028_bib0031","doi-asserted-by":"crossref","first-page":"463","DOI":"10.12659\/MSM.890635","article-title":"Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation","volume":"20","author":"Sonmez","year":"2014","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.ejim.2025.05.028_bib0032","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ancard.2014.12.004","article-title":"MMP-9 in atrial remodeling in patients with atrial fibrillation","volume":"64","author":"Lewkowicz","year":"2015","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1016\/j.ejim.2025.05.028_bib0033","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1253\/circj.CJ-20-0149","article-title":"Impact of renal dysfunction on left atrial structural remodeling and recurrence after catheter ablation for atrial fibrillation - A propensity score matching analysis","volume":"84","author":"Takahashi","year":"2020","journal-title":"Circ J"},{"key":"10.1016\/j.ejim.2025.05.028_bib0034","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2215\/CJN.06140710","article-title":"Neutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward","volume":"6","author":"Alvelos","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ejim.2025.05.028_bib0035","doi-asserted-by":"crossref","first-page":"37258","DOI":"10.1074\/jbc.M106089200","article-title":"The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B\/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL","volume":"276","author":"Yan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejim.2025.05.028_bib0036","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000448225","article-title":"Matrix metalloproteinase neutrophil gelatinase-associated lipocalin complex predicts atrial fibrillation recurrence after electrical cardioversion in obese patients","volume":"7","author":"Mlodawska","year":"2016","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.ejim.2025.05.028_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168889","article-title":"GDF15 and cardiac cells: current +concepts and new insights","volume":"22","author":"Rochette","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2025.05.028_bib0038","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/heartjnl-2016-309764","article-title":"Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip","volume":"103","author":"Lind","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2025.05.028_bib0039","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/clinchem\/hvac096","article-title":"Growth differentiation factor 15 and the subsequent risk of atrial fibrillation: the atherosclerosis risk in communities study","volume":"68","author":"Chen","year":"2022","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2025.05.028_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.899667","article-title":"Relationship between serum growth differentiation factor 15, fibroblast growth factor-23 and risk of atrial fibrillation: a systematic review and meta-analysis","volume":"9","author":"Tan","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ejim.2025.05.028_bib0041","first-page":"11","article-title":"Pericardial NT-pro-BNP and GDF-15 as biomarkers of atrial fibrillation and atrial matrix remodeling in aortic stenosis","author":"Fragao-Marques","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.ejim.2025.05.028_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129274","article-title":"The effect of catheter ablation on left atrial size and function for patients with atrial fibrillation: an updated meta-analysis","volume":"10","author":"Xiong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2025.05.028_bib0043","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood.V84.10.3483.3483","article-title":"Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes","volume":"84","author":"Alles","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2025.05.028_bib0044","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00380-013-0400-8","article-title":"Pentraxin 3 is a local inflammatory marker in atrial fibrillation","volume":"29","author":"Soeki","year":"2014","journal-title":"Heart Vessels"},{"key":"10.1016\/j.ejim.2025.05.028_bib0045","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1177\/2047487319859974","article-title":"Exercise-based cardiac rehabilitation for patients with catheter ablation for persistent atrial fibrillation: a randomized controlled clinical trial","volume":"26","author":"Kato","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejim.2025.05.028_bib0046","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1136\/hrt.2009.191460","article-title":"Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial","volume":"96","author":"Masson","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2025.05.028_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejim.2025.05.028_bib0048","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1253\/circj.CJ-09-0644","article-title":"Recruitment of immune cells across atrial endocardium in human atrial fibrillation","volume":"74","author":"Yamashita","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.ejim.2025.05.028_bib0049","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/ATVBAHA.108.178947","article-title":"Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study","volume":"29","author":"Jenny","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ejim.2025.05.028_bib0050","first-page":"313","article-title":"Pentraxin-3 vs C-reactive protein and other prognostic biomarkers in acute coronary syndrome: a substudy of the Platelet Inhibition and Patients Outcomes (PLATO) trial","volume":"9","author":"Kontny","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ejim.2025.05.028_bib0051","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.atherosclerosis.2011.11.036","article-title":"Pentraxin 3: a novel and independent prognostic marker in ischemic stroke","volume":"220","author":"Ryu","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2025.05.028_bib0052","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1956","article-title":"Serum pentraxin 3 as a biomarker for prognosis of acute minor stroke due to large artery atherosclerosis","volume":"11","author":"Zhang","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/j.ejim.2025.05.028_bib0053","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000504529","article-title":"Biomarkers associated with atrial fibrillation in patients with ischemic stroke: a pilot study from the NOR-FIB study","volume":"10","author":"Tancin Lambert","year":"2020","journal-title":"Cerebrovasc Dis Extra"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525002201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525002201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T02:27:39Z","timestamp":1756693659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525002201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":53,"alternative-id":["S0953620525002201"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.05.028","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic markers of inflammation and immune activation in patients with obstructive sleep apnea and paroxysmal atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}],"article-number":"106363"}}